These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 9636480

  • 1. Selective CellCept therapy in high-risk renal transplant recipients.
    Isenberg A, Singh TP, Shen GK, Freed BM, Conti DJ.
    Transplant Proc; 1998 Jun; 30(4):1188-9. PubMed ID: 9636480
    [No Abstract] [Full Text] [Related]

  • 2. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP, Weinreich T, Schwarzkopf AK, Candinas D, Binswanger U.
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish Group. Spanish Group of the CellCept Study.
    Puig i Marí JM.
    Transplant Proc; 1999 Sep; 31(6):2256-8. PubMed ID: 10500566
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Steroid withdrawal in renal transplant recipients.
    Oppenheimer F.
    Transplant Proc; 2000 Feb; 32(1A Suppl):14S-15S. PubMed ID: 10686314
    [No Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil (Cellcept) in renal transplantation: the European experience. The European Mycophenolate Mofetil Co-operative Study Group.
    Carl S, Wiesel M.
    Transplant Proc; 1997 Nov; 29(7):2932-5. PubMed ID: 9365619
    [No Abstract] [Full Text] [Related]

  • 13. Clinical study of FK 506 in renal transplant recipients.
    Youhua Z, Zhinlian M, Liming W.
    Transplant Proc; 2000 Nov; 32(7):1704. PubMed ID: 11119900
    [No Abstract] [Full Text] [Related]

  • 14. Failure of ganciclovir prophylaxis of primary cytomegalovirus disease in immunologic high-risk recipients.
    Conti DJ, Isenberg A, Shen GK, Hahn A, Singh TP.
    Transplant Proc; 1998 Jun; 30(4):1314-5. PubMed ID: 9636533
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
    Transplant Proc; 1997 Jun; 29(1-2):348-9. PubMed ID: 9123033
    [No Abstract] [Full Text] [Related]

  • 18. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.
    Weber M, Ketchum RJ, Sellers M, Aradhye S, Deng S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL.
    Transplant Proc; 1997 Jun; 29(1-2):338-9. PubMed ID: 9123029
    [No Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM, Donadi MO, Oliveira ML, Ponte CN, Pinheiro PM.
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.